Our Doctors

Dr. Ali Albayer MD

Registrar, Medical Oncology

Oncology | 13 years of experience | Speaks English, Arabic

Areas of Expertise:

  • Treatments: Immunotherapy, Targeted Therapy
    • +more
"Success is a science; if you have the conditions, you get the result."
  • Biography
  • Education & Training
  • Licenses & Certifications
  • Publications & Books
  • Professional Affiliations
  • Areas of Expertise

Dr. Ali Albayer is a highly qualified medical oncologist with over 13 years of extensive experience in the field. Throughout his career, he has developed the essential knowledge and compassion required to support cancer patients and their families during the challenging journey of this serious illness. Dr. Albayer has been actively involved in numerous clinical trials and research projects in medical oncology, focusing on cutting-edge treatments that offer better options for patient care.

He is committed to staying current with the latest advancements in oncology. Coupled with his strong research background, this dedication ensures that Dr. Albayer remains a professional oncologist dedicated to providing the highest standard of care to his patients.

Master’s Degree in Medical Oncology (2011)

Graduation Thesis on Breast Cancer, Al-Bairouni Hospital, Damascus University (Defended March 2011)

Higher Education Training in Oncology, Nuclear Medicine Center and Al-Bairouni University Hospital, Department of Oncology, Damascus University (Oct 2005 – Oct 2009)

Higher Education Training in Anesthesia and Intensive Care, Faculty of Medicine, Damascus University (Jan 2005 – July 2005)

MD (2004)

Internship, Damascus University Hospitals, Faculty of Medicine (2002-2004)

Master’s Degree in Medical Oncology, 2011

Diploma of Doctor in Medicine (MD), 2004

Genomic Profiling of Breast Cancer: A Single Institution’s Experience and Impact on Patient Outcomes. International Journal of Cancer and Clinical Research, Feb 2024.

Combination of Palbociclib with Adjuvant Endocrine Therapy for Treatment of Hormone Receptor‑Positive and Human Epidermal Growth Factor Receptor 2‑Negative Metastatic Breast Cancer: An Experience at Two Cancer Centers in Saudi Arabia. Published in Molecular and Clinical Oncology Journal, June 2022.

Poly (ADP-ribose) Polymerase Inhibitors as Maintenance Treatment in Patients with Newly Diagnosed Advanced Ovarian Cancer: A Meta-Analysis, March 2020.

Genomic Profiling for Patients with Solid Tumors: A Single-Institution Experience, Aug 2019.

Extended Adjuvant Endocrine Therapy in Early Breast Cancer: A Meta-Analysis of Published Randomized Trials. Published in Medical Oncology Journal, Jul 2017.

Bleomycin Pulmonary Toxicity in Adult Saudi Patients with Hodgkin’s Lymphoma. Presented at the 56th American Society of Hematology Annual Meeting, and published in Dec 2014.

Another Look at Treatment Choices for Metastatic Renal Cell Carcinoma. Published online article, Jul 2013.

Sunitinib Adverse Events in Metastatic Renal Cell Carcinoma: A Meta-Analysis. Published in International Journal of Clinical Oncology, Nov 2012.

Increased Risk of Second Lung Cancer in Hodgkin’s Lymphoma Survivors: A Meta-Analysis. Published in Lung Journal, Oct 2012.

  • Solid Tumors: Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Gastrointestinal Tract Cancers
  • Hematology Malignancies: Lymphoma, Leukemia Novel Anticancer
  • Treatments: Immunotherapy, Targeted Therapy

Menu

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.